Virtual Presentation

Tailoring HCV Treatment to Patients With Advanced Liver Disease

Source: Minimizing Barriers and Maximizing Response: Strategies and Tools for Frontline Providers Caring for Patients With Chronic Hepatitis C

Tailoring HCV Treatment to Patients With Advanced Liver Disease

Program Director: Michael W. Fried, MD

Faculty:

Douglas M. Heuman, MD, FACP
HoChong Gilles, RN, MS, FNP
Lisa Pisney, RN, MSN, ANP-C

CME CREDIT INFORMATION

Release Date: 09/18/08

Expiration Date: 09/17/09

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss both the benefits of achieving sustained virologic response and the limitations of antiviral treatment in HCV patients with fibrosis and cirrhosis
Evaluate current approaches to address cytopenias during HCV treatment in patients with advanced liver disease
Describe data assessing the efficacy of a low accelerating dose regimen in the treatment of HCV patients with decompensated cirrhosis
Identify risk factors associated with progressive HCV and recurrent cirrhosis following liver transplantation

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.